These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24573600)

  • 21. Dynamic structure based pharmacophore modeling of the Acetylcholinesterase reveals several potential inhibitors.
    Shiri F; Pirhadi S; Ghasemi JB
    J Biomol Struct Dyn; 2019 Apr; 37(7):1800-1812. PubMed ID: 29695192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study.
    Rosenberry TL; Brazzolotto X; Macdonald IR; Wandhammer M; Trovaslet-Leroy M; Darvesh S; Nachon F
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular characterization of monoclonal antibodies that inhibit acetylcholinesterase by targeting the peripheral site and backdoor region.
    Bourne Y; Renault L; Essono S; Mondielli G; Lamourette P; Boquet D; Grassi J; Marchot P
    PLoS One; 2013; 8(10):e77226. PubMed ID: 24146971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors tethered near the acetylcholinesterase active site serve as molecular rulers of the peripheral and acylation sites.
    Johnson JL; Cusack B; Hughes TF; McCullough EH; Fauq A; Romanovskis P; Spatola AF; Rosenberry TL
    J Biol Chem; 2003 Oct; 278(40):38948-55. PubMed ID: 12851386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target.
    Harel M; Kleywegt GJ; Ravelli RB; Silman I; Sussman JL
    Structure; 1995 Dec; 3(12):1355-66. PubMed ID: 8747462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limitations in current acetylcholinesterase structure-based design of oxime antidotes for organophosphate poisoning.
    Kovalevsky A; Blumenthal DK; Cheng X; Taylor P; Radić Z
    Ann N Y Acad Sci; 2016 Aug; 1378(1):41-49. PubMed ID: 27371941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and anti-acetylcholinesterase activity of 4 alpha-(hydroxymethyl)-4 alpha-demethylterritrem B.
    Peng FC
    J Nat Prod; 1997 Aug; 60(8):842-3. PubMed ID: 9287420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The fasciculin-acetylcholinesterase interaction].
    Marchot P
    J Soc Biol; 1999; 193(6):505-8. PubMed ID: 10783708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect.
    Szegletes T; Mallender WD; Thomas PJ; Rosenberry TL
    Biochemistry; 1999 Jan; 38(1):122-33. PubMed ID: 9890890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands.
    Szegletes T; Mallender WD; Rosenberry TL
    Biochemistry; 1998 Mar; 37(12):4206-16. PubMed ID: 9521743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate.
    Johnson JL; Cusack B; Davies MP; Fauq A; Rosenberry TL
    Biochemistry; 2003 May; 42(18):5438-52. PubMed ID: 12731886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterocyclic inhibitors of AChE acylation and peripheral sites.
    Bolognesi ML; Andrisano V; Bartolini M; Cavalli A; Minarini A; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
    Farmaco; 2005; 60(6-7):465-73. PubMed ID: 15878569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates.
    Ekström F; Pang YP; Boman M; Artursson E; Akfur C; Börjegren S
    Biochem Pharmacol; 2006 Aug; 72(5):597-607. PubMed ID: 16876764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural insights into substrate traffic and inhibition in acetylcholinesterase.
    Colletier JP; Fournier D; Greenblatt HM; Stojan J; Sussman JL; Zaccai G; Silman I; Weik M
    EMBO J; 2006 Jun; 25(12):2746-56. PubMed ID: 16763558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of Ligands Binding Acetylcholinesterase with Potential Antidotal Activity: A Virtual Screening Approach.
    Ochoa R; Rodriguez CA; Zuluaga AF
    Mol Inform; 2019 Jun; 38(6):e1800126. PubMed ID: 30950246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylthiocholine binds to asp74 at the peripheral site of human acetylcholinesterase as the first step in the catalytic pathway.
    Mallender WD; Szegletes T; Rosenberry TL
    Biochemistry; 2000 Jul; 39(26):7753-63. PubMed ID: 10869180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of snake venom acetylcholinesterase in complex with inhibitory antibody fragment Fab410 bound at the peripheral site: evidence for open and closed states of a back door channel.
    Bourne Y; Renault L; Marchot P
    J Biol Chem; 2015 Jan; 290(3):1522-35. PubMed ID: 25411244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly functionalized 2-amino-4H-pyrans as potent cholinesterase inhibitors.
    Kumar RS; Almansour AI; Arumugam N; Al-Thamili DM; Basiri A; Kotresha D; Manohar TS; Venketesh S; Asad M; Asiri AM
    Bioorg Chem; 2018 Dec; 81():134-143. PubMed ID: 30121001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level.
    Millard CB; Kryger G; Ordentlich A; Greenblatt HM; Harel M; Raves ML; Segall Y; Barak D; Shafferman A; Silman I; Sussman JL
    Biochemistry; 1999 Jun; 38(22):7032-9. PubMed ID: 10353814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.
    Kryger G; Silman I; Sussman JL
    Structure; 1999 Mar; 7(3):297-307. PubMed ID: 10368299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.